KAT Innovation develops the OSTAAT™ wearable device that utilizes bone growth simulation technology to combat osteoporosis-related hip fractures in the elderly and chronic renal failure patients. This device addresses the significant health risks and high healthcare costs associated with osteoporotic fractures, which affect millions globally.
Funding
$140K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Osteoporosis and related conditions like chronic renal failure lead to significant bone loss, increasing the risk of hip fractures, especially in the elderly. These fractures result in high healthcare costs, reduced quality of life, and increased mortality rates, with a substantial portion of hip fracture patients dying within a year of surgery. Traditional methods of preventing bone loss often prove insufficient in these high-risk populations.
Solution
KAT Innovation has developed OSTAAT™, a wearable device designed to stimulate bone growth and combat osteoporosis-related hip fractures. The device utilizes bone growth simulation technology to deliver targeted stimulation, promoting bone density and strength. By addressing bone loss directly, OSTAAT™ aims to reduce the incidence of fractures, improve patient outcomes, and lower the overall healthcare burden associated with osteoporosis and related conditions. The wearable form factor allows for convenient and consistent application of the bone growth stimulation technology.
Target Audience
The primary target audience includes elderly individuals at high risk of osteoporotic hip fractures, as well as chronic renal failure patients experiencing secondary osteoporosis.
Features
- Wearable device for convenient, consistent application
- Bone growth simulation technology to stimulate bone density
- Targeted stimulation to promote bone strength in high-risk areas